IP Library › Granted Patent US 11,446,505
Granted Patent B2
US 11,446,505 · App. 16/886,531 · Granted Sep 20, 2022

His-bundle pacing for atrioventricular block

Inventors: Allan Charles Shuros (St. Paul, MN); David Arthur Casavant (Reading, MA)
Assignee: Cardiac Pacemakers, Inc.
A61N1/36585A61N1/36542A61N1/36592
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,446,505
App. No.
16/886,531
Granted
Sep 20, 2022
Kind
B2
Abstract

Systems and methods for dynamically controlling His-bundle pacing (HBP) according to an indication of a rate-related or intermittent atrioventricular (AV) block in a subject are disclosed. An exemplary medical system includes an AV conduction monitor to detect an indication of either a presence or an absence of intermittent or rate-related AV conduction disturbance using physiologic information of the subject. In the event that an intermittent or rate-related AV conduction disturbance is present, a control circuit provides a control signal to an electrostimulation circuit to deliver HBP pulses. If there is no indication of intermittent or rate-related AV conduction disturbance, or a previously detected intermittent or rate-related AV conduction disturbance has been terminated, the control circuit withholds or discontinues delivery of the HBP pulses to promote intrinsic ventricular conduction and activation.

Claims (59)

1. A system, comprising:

an atrioventricular (AV) conduction monitor configured to:

receive physiologic information of a subject, the received physiologic information including a heart rate (HR);

determine for the subject, using the received physiologic information of the subject, a personalized HR threshold at and above which an intermittent or rate-related AV conduction disturbance occurs; and

detect an indication of either a presence or an absence of the intermittent or rate-related AV conduction disturbance in a heart of the subject using the received HR and the personalized HR threshold; and

a pacing control circuit configured to control an electrostimulation circuit to generate His-bundle pacing (HBP) pulses, and to provide a control signal to:

deliver HBP pulses to stimulate a physiologic conduction pathway of the heart in response to a detected indication of a presence of intermittent or rate-related AV conduction disturbance; and

withhold or discontinue delivery of the HBP pulses in response to a detected indication of an absence of intermittent or rate-related AV conduction disturbance.

2. The system of claim 1 , wherein the AV conduction monitor is configured to:

determine the personalized HR threshold using intrinsic or paced AV conduction data of the subject; and

detect an indication of a presence of intermittent or rate-related AV conduction disturbance in response to the HR exceeding the personalized HR threshold, or an indication of an absence of intermittent or rate-related AV conduction disturbance in response to the HR is below the personalized HR threshold.

3. The system of claim 2 , wherein the HR includes a sensed atrial heart rate.

4. The system of claim 3 , wherein the HR includes an atrial pacing rate driven by a physiologic sensor.

5. The system of claim 2 , wherein the AV conduction monitor is configured to monitor HR during the delivery of the HBP pulses, and the pacing control circuit is configured to provide a control signal to:

continue delivery of the HBP pulses in response to the indication of a presence of intermittent or rate-related AV conduction disturbance; and

discontinue delivery of the HBP pulses in response to the indication of an absence of intermittent or rate-related AV conduction disturbance.

6. The system of claim 1 , wherein the AV conduction monitor is configured to:

determine a QRS width metric; and

detect an indication of a presence of intermittent AV conduction disturbance in response to the QRS width metric exceeding a QRS width threshold, or an indication of an absence of intermittent AV conduction disturbance in response to the QRS width metric falling below the QRS width threshold.

7. The system of claim 1 , wherein the physiologic information includes cardiac acceleration information indicative of heart sounds (HS).

8. The system of claim 7 , wherein the cardiac acceleration information includes an S1 heart sound intensity metric, and wherein the AV conduction monitor is configured to detect an indication of a presence of intermittent AV conduction disturbance in response to the S1 heart sound intensity metric falling below an S1 intensity threshold, or an indication of an absence of intermittent AV conduction disturbance in response to the S1 heart sound intensity metric exceeding the S1 intensity threshold.

9. The system of claim 1 , wherein the physiologic includes a cardiac timing information.

10. The system of claim 9 , wherein the cardiac timing information includes a pre-ejection period (PEP), and wherein the AV conduction monitor is configured to detect an indication of a presence of intermittent AV conduction disturbance in response to the PEP exceeding a PEP threshold, or an indication of an absence of intermittent AV conduction disturbance in response to the PEP falling below the PEP threshold.

11. The system of claim 1 , wherein:

the AV conduction monitor is configured to monitor a physiologic parameter different from HR; and

the pacing control circuit is configured to, in response to the monitored HR exceeding the personalized HR threshold, trigger the AV conduction monitor to detect an indication of presence or absence of intermittent or rate-dependent AV conduction disturbance using the physiologic parameter.

12. The system of claim 1 , wherein the AV conduction monitor is configured to:

monitor a physiologic parameter different from HR;

detect the indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance using the physiologic parameter; and

detect a HR corresponding to the detected indication of presence of intermittent or rate-related AV conduction disturbance; and

wherein the pacing control circuit is configured to provide a control signal to deliver, or withhold or discontinue, the HBP pulses using the detected HR corresponding to the detected indication of presence of intermittent or rate-related AV conduction disturbance.

13. The system of claim 12 , comprising an output circuit configured to display the detected HR corresponding to the detected intermittent or rate-related AV conduction disturbance.

14. A method for pacing a physiologic conduction pathway including a His bundle or a bundle branch of a heart of a subject, the method comprising:

receiving physiologic information of the subject using an atrioventricular (AV) conduction monitor, the received physiologic information including a heart rate (HR);

determining for the subject, using the received physiologic information of the subject, a personalized HR threshold at and above which an intermittent or rate-related AV conduction disturbance occurs using the AV conduction monitor;

detecting, using the AV conduction monitor, an indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance in the heart of the subject using the received HR and the personalized HR threshold; and

controlling, using a pacing control circuit, generation of His-bundle pacing (HBP) pulses of an electrostimulation circuit, comprising:

in response to an indication of a presence of intermittent or rate-related AV conduction disturbance, delivering HBP pulses to stimulate a physiologic conduction pathway; and

in response to an indication of an absence of intermittent or rate-related AV conduction disturbance, withholding or discontinuing delivery of the HBP pulses.

15. The method of claim 14 , wherein detecting an indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance includes:

determining the personalized HR threshold using intrinsic or paced AV conduction data of the subject; and

detecting an indication of a presence of intermittent or rate-related AV conduction disturbance in response to the HR exceeding the personalized HR threshold, or an indication of an absence of intermittent or rate-related AV conduction disturbance in response to the HR is below the personalized HR threshold.

16. The method of claim 14 , wherein detecting an indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance includes:

determining a QRS width metric; and

detecting an indication of a presence of intermittent AV conduction disturbance in response to the QRS width metric exceeding a QRS width threshold, or an indication of an absence of intermittent AV conduction disturbance in response to the QRS width metric falling below the QRS width threshold.

17. The method of claim 14 , wherein detecting an indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance includes:

determining an S1 heart sound intensity metric; and

detecting an indication of a presence of intermittent AV conduction disturbance in response to the S1 heart sound intensity metric falling below an S1 intensity threshold, or an indication of an absence of intermittent AV conduction disturbance in response to the S1 heart sound intensity metric exceeding the S1 intensity threshold.

18. The method of claim 14 , wherein detecting an indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance includes:

determining a pre-ejection period (PEP); and

detecting an indication of a presence of intermittent AV conduction disturbance in response to the PEP exceeding a PEP threshold, or an indication of an absence of intermittent AV conduction disturbance in response to the PEP falling below the PEP threshold.

19. The method of claim 14 , comprising:

monitoring a physiologic parameter different from HR; and

in response to the monitored HR exceeding a HR threshold, triggering the detection of an indication of presence or absence of intermittent or rate-dependent AV conduction disturbance using the physiologic parameter.

20. The method of claim 14 , comprising:

monitoring a physiologic parameter different from HR;

detecting the indication of either a presence or an absence of an intermittent or rate-related AV conduction disturbance using the physiologic parameter;

detecting a HR corresponding to the detected indication of presence of intermittent or rate-related AV conduction disturbance; and

providing a control signal to deliver, or withhold or discontinue, the HBP pulses using the detected HR corresponding to the detected indication of presence of intermittent or rate-related AV conduction disturbance.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2020
From: SHUROS, ALLAN CHARLES; CASAVANT, DAVID ARTHUR
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 053291/0522 →
Continuity (2)
Provisional Application 62855396 · May 31, 2019
Related Publication 20200376280A1 · Dec 3, 2020